Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin in coma after cardiac arrest
NL-OMON20553Phase 2Not yet recruiting
- Sponsor
- University of Twente
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anoxic encephalopathy and coma comparing Acylated ghrelin with Placebo (2 arms). Primary endpoints: Functional outcome at 6 months and Safety. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
acyl-ghrelin
03
Conditions
anoxic encephalopathycoma
Beyond the preview
Go deeper on NL-OMON20553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20553.